Technology is well and truly embedded within the lives of people
of all ages, geographic locations and economic backgrounds,
ultimately driven by the increasing sophistication and associated
reduction in cost of using emerging technology for all kinds of
applications. In line with this, the ownership and use of smartphones
has become extensive – in fact, it is estimated that by the end of
2016, the number of smartphone users worldwide will exceed two
billion. With increasingly tech-savvy consumers, the pharmaceutical
industry has reached a point when it can finally begin to consider
utilising the low-friction, rich, real-time data that can be captured
using patients’ own devices. Paul O’Donohoe, Director of Health
Outcomes at CRF Health, answers the question: is BYOD always the
best approach?
https://international-pharma.com/wp-content/uploads/2016/07/Tech-1-The-Future.pdf